In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity
Open Access
- 1 April 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (7) , 2871-2878
- https://doi.org/10.1182/blood-2005-07-3014
Abstract
Bone marrow-derived antigen-presenting cells (APCs) play a central role in the induction of tolerance to tumor antigens expressed by B-cell lymphomasKeywords
This publication has 33 references indexed in Scilit:
- Antigen presentation to naive CD4 T cells in the lymph nodeNature Immunology, 2003
- The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic CellsThe Journal of Experimental Medicine, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Tumors derived from antigen presenting cellsSeminars in Immunology, 1996
- Malignant B lymphocytes from non‐Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: An important role of co‐stimulatory molecules CD80 (B7‐1) and CD86 (B7‐2) in stimulation by tumor cellsEuropean Journal of Immunology, 1995
- Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.The Journal of Experimental Medicine, 1994
- How B and T cells talk to each otherNature, 1994
- Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.The Journal of Experimental Medicine, 1993
- B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.The Journal of Experimental Medicine, 1993
- Antigen-specific interaction between T and B cellsNature, 1985